CTLA4 and myocarditis: Second, it has been reported that combined therapy of CTLA-4 and PD1/PDL1 inhibitors are more likely to induce myocarditis compared with monotherapy of PD1/PDL1 inhibitors [6, 10, 12, 27, 47].